149 related articles for article (PubMed ID: 30099128)
1. The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
Yavuz A; Bayar G; Kilinc MF; Sariogullari U
Urology; 2018 Oct; 120():216-221. PubMed ID: 30099128
[TBL] [Abstract][Full Text] [Related]
2. Spina bifida occulta: not to be overlooked in children with nocturnal enuresis.
Shin SH; Im YJ; Lee MJ; Lee YS; Choi EK; Han SW
Int J Urol; 2013 Aug; 20(8):831-5. PubMed ID: 23294087
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal enuresis with spina bifida occulta: Does it interfere behavioral management success?
Kurt O; Yazici CM; Paketci C
Int Urol Nephrol; 2015 Sep; 47(9):1485-91. PubMed ID: 26149636
[TBL] [Abstract][Full Text] [Related]
4. The adverse influence of spina bifida occulta on the medical treatment outcome of primary monosymptomatic nocturnal enuresis.
Cakiroglu B; Tas T; Eyyupoglu SE; Hazar AI; Can Balcı MB; Nas Y; Yilmazer F; Aksoy SH
Arch Ital Urol Androl; 2014 Dec; 86(4):270-3. PubMed ID: 25641449
[TBL] [Abstract][Full Text] [Related]
5. Spina bifida occulta: is it a predictor of underlying spinal cord abnormality in patients with lower urinary tract dysfunction?
Nejat F; Radmanesh F; Ansari S; Tajik P; Kajbafzadeh A; El Khashab M
J Neurosurg Pediatr; 2008 Feb; 1(2):114-7. PubMed ID: 18352778
[TBL] [Abstract][Full Text] [Related]
6. Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
Rittig N; Hagstroem S; Mahler B; Kamperis K; Siggaard C; Mikkelsen MM; Bower WF; Djurhuus JC; Rittig S
Neurourol Urodyn; 2014 Jun; 33(5):475-81. PubMed ID: 23765698
[TBL] [Abstract][Full Text] [Related]
7. Constipation in nocturnal enuresis may interfere desmopressin management success.
Ma Y; Shen Y; Liu X
J Pediatr Urol; 2019 Apr; 15(2):177.e1-177.e6. PubMed ID: 30594475
[TBL] [Abstract][Full Text] [Related]
8. Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children.
Miyazato M; Sugaya K; Nishijima S; Owan T; Ogawa Y
Int J Urol; 2007 Jan; 14(1):33-8. PubMed ID: 17199857
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
10. Hereditary phenotypes in nocturnal enuresis.
Schaumburg HL; Kapilin U; Blåsvaer C; Eiberg H; von Gontard A; Djurhuus JC; Rittig S
BJU Int; 2008 Sep; 102(7):816-21. PubMed ID: 18564134
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment to spina bifida occulta: not to be overlooked in children with nocturnal enuresis.
Kumar P
Int J Urol; 2013 Aug; 20(8):836. PubMed ID: 23380002
[No Abstract] [Full Text] [Related]
12. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
[TBL] [Abstract][Full Text] [Related]
13. Spina bifida occulta in functional enuresis.
Kumar P; Aneja S; Kumar R; Taluja V
Indian J Pediatr; 2005 Mar; 72(3):223-5. PubMed ID: 15812117
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options in childhood nocturnal enuresis.
Zaffanello M; Giacomello L; Brugnara M; Fanos V
Minerva Urol Nefrol; 2007 Jun; 59(2):199-205. PubMed ID: 17571056
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
16. Possible impact of comorbid conditions on the persistence of nocturnal enuresis: results of a long-term follow-up study.
Ferrara P; De Angelis MC; Caporale O; Malamisura M; Del Volgo V; Vena F; Gatto A; Chiaretti A
Urol J; 2014 Sep; 11(4):1777-82. PubMed ID: 25194075
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
18. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
19. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
[TBL] [Abstract][Full Text] [Related]
20. [Nocturnal enuresis in children--how to diagnose, how to treat?].
Paruszkiewicz G
Wiad Lek; 2013; 66(1):35-44. PubMed ID: 23905426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
